Publication | Open Access
Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
151
Citations
34
References
2014
Year
The immune response induced by this vaccine may improve the prognosis of patients with advanced HNSCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1